Search Results - Maria Buti

Refine Results
  1. 1
    Management of direct antiviral agent failures

    Management of direct antiviral agent failures by Marı́a Buti, Rafael Esteban

    Published 2016
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Natural History and Management of Hepatitis C: Does Sex Play a Role?

    Natural History and Management of Hepatitis C: Does Sex Play a Role? by Rachel Baden, Jürgen K. Rockstroh, Marı́a Buti

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Long‐term safety and efficacy of nucleo(t)side analogue therapy in hepatitis B

    Long‐term safety and efficacy of nucleo(t)side analogue therapy in hepatitis B by Marı́a Buti, Mar Riveiro‐Barciela, Rafael Esteban

    Published 2018
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Long-term efficacy and safety of nucleos(t)ides analogues in patients with chronic hepatitis B

    Long-term efficacy and safety of nucleos(t)ides analogues in patients with chronic hepatitis B by Luisa Roade, Mar Riveiro‐Barciela, Rafael Esteban, Marı́a Buti

    Published 2021
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients

    EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients by Markus Cornberg, Marı́a Buti, Christiane S. Eberhardt, Paolo Grossi, Daniel Shouval

    Published 2021
    Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference

    Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoint... by Marc G. Ghany, Marı́a Buti, Pietro Lampertico, Hannah M. Lee

    Published 2023
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Genetic analysis of hepatitis A virus strains recovered from the environment and from patients with acute hepatitis

    Genetic analysis of hepatitis A virus strains recovered from the environment and from patients with acute hepatitis by Sonia Pina-Pedrero, Marı́a Buti, R Jardí, Pilar Clemente-Casares, Joan Jofre, Rosina Gironés

    Published 2001
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Hepatitis B virus infection: Precore mutants and its relation to viral genotypes and core mutations

    Hepatitis B virus infection: Precore mutants and its relation to viral genotypes and core mutations by Francisco Rodríguez‐Frías, Marı́a Buti, Rosendo Jardí, Montserrat Cotrina, L Viladomiu, Rafael Esteban, Jaime Guardia

    Published 1995
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Consensus document of the Spanish Association for Study of the Liver on the treatment of hepatitis B virus infection (2020)

    Consensus document of the Spanish Association for Study of the Liver on the treatment of hepatitis B virus infection (2020) by Manuel Rodríguez, Marı́a Buti, Rafael Esteban, Sabela Lens, M. Prieto, Emilio Suárez, Javier García‐Samaniego

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Role of hepatitis B, C, and D viruses in dual and triple infection: Influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference

    Role of hepatitis B, C, and D viruses in dual and triple infection: Influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative inte... by Rosendo Jardí, F. Rodrı́guez, Marı́a Buti, X. Costa, Montserrat Cotrina, R. Galimany, Rafael Esteban, Jaime Guardia

    Published 2001
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Viral kinetics in genotype 1 chronic hepatitis C patients during therapy with 2 different doses of peginterferon alfa-2b plus ribavirin

    Viral kinetics in genotype 1 chronic hepatitis C patients during therapy with 2 different doses of peginterferon alfa-2b plus ribavirin by Marı́a Buti, J.F. Sánchez-Ávila, Yoav Lurie, Carlos Stalgis, Auristela Valdés, M. Martell, Rafael Esteban

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Impact of the COVID-19 pandemic on hepatitis B and C elimination: An EASL survey

    Impact of the COVID-19 pandemic on hepatitis B and C elimination: An EASL survey by Loreta A. Kondili, Marı́a Buti, Mar Riveiro‐Barciela, Mojca Matičič, Francesco Negro, Thomas Berg, Antonio Craxı̀

    Published 2022
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Hepatitis E Virus Epidemiology in Industrialized Countries

    Hepatitis E Virus Epidemiology in Industrialized Countries by Pilar Clemente-Casares, Sonia Pina-Pedrero, Marı́a Buti, R Jardí, Marga Martı́n, Sílvia Bofill-Mas, Rosina Gironés

    Published 2003
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Direct‐acting antiviral treatment for hepatitis C virus infection and risk of incident liver cancer: a retrospective cohort study

    Direct‐acting antiviral treatment for hepatitis C virus infection and risk of incident liver cancer: a retrospective cohort study by A. Singer, K. Rajender Reddy, Laura Telep, Anu Osinusi, Diana M. Brainard, Marı́a Buti, Anand P. Chokkalingam

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Acute liver failure due to immune-mediated hepatitis successfully managed with plasma exchange: New settings call for new treatment strategies?

    Acute liver failure due to immune-mediated hepatitis successfully managed with plasma exchange: New settings call for new treatment strategies? by Mar Riveiro‐Barciela, Eva Muñoz‐Couselo, Jesús Fernández‐Sojo, Nely Díaz‐Mejía, Rafael Parra-López, Marı́a Buti

    Published 2018
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  16. 16
    Clinical outcome of acute and chronic hepatitis delta over time: a long-term follow-up study

    Clinical outcome of acute and chronic hepatitis delta over time: a long-term follow-up study by Marı́a Buti, María Homs, Francisco Rodríguez‐Frías, G. Funalleras, Rosendo Jardí, Sílvia Sauleda, David Tabernero, M. Schaper, Rafael Esteban

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Adherence to Lamivudine After an Early Withdrawal of Hepatitis B Immune Globulin Plays an Important Role in the Long-Term Prevention of Hepatitis B Virus Recurrence

    Adherence to Lamivudine After an Early Withdrawal of Hepatitis B Immune Globulin Plays an Important Role in the Long-Term Prevention of Hepatitis B Virus Recurrence by Marı́a Buti, Antoni Mas, M. Prieto, Fernando Casafont, Antonio González, Manuel Miras, J.I. Herrero, Rosendo Jardí, Rafael Esteban

    Published 2007
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Clinical and economic value of bulevirtide in the treatment of chronic hepatitis D

    Clinical and economic value of bulevirtide in the treatment of chronic hepatitis D by Marı́a Buti, José Luís Calleja, Miguel Ángel Rodríguez, Raquel Domínguez‐Hernández, Helena Cantero, Nataly Espinoza-Cámac, Miguel Á. Casado

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B …

    Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with he... by Nicolaos C. Tassopoulos, Riccardo Volpes, Giuseppe Pastore, Jenny Heathcote, Marı́a Buti, Robert Goldin, Sasha Hawley, Judy Barber, Lynn D. Condreay, Fraser Gray

    Published 1999
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Community-Based Seroepidemiological Survey of Hepatitis E Virus Infection in Catalonia, Spain

    Community-Based Seroepidemiological Survey of Hepatitis E Virus Infection in Catalonia, Spain by Marı́a Buti, Ángela Domı́nguez, Pere Plans, Rossend Jardí, M. Schaper, Jordi Espuñes, Neus Cardeñosa, Francisco Rodríguez‐Frías, Rafael Esteban, Antoni Plasència, L. Salleras

    Published 2006
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: